BSE filing, BSE: 544831. Summary written from the filing by ALFA Finder's alert engine.
Meenakshi (India) Ltd: key numbers
- Share price
- ₹383.60
- Market cap
- ₹431.6 Cr
- P/E (TTM)
- 29.2×Sector 49.5×
- Promoter holding
- 71.22%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Meenakshi (India) Ltd
All →Meenakshi (India) Stock Split
Meenakshi (India) Ltd confirmed the new ISIN (INE208H01024) for its Rs.10-to-Rs.5 equity share split. The split takes effect on record date October 30, 2026.
Meenakshi (India) Investor Presentation: Key Takeaways
Meenakshi India Ltd reports Q1FY27 recovery with revenue of ₹32 Cr and PAT growth of 152.8% YoY. Strategy centers on premium woven apparel, vertical integration, and capacity doubling by FY30.
- Call
- Guides 35% growth
Meenakshi (India) Stock Split
Meenakshi (India) Limited has fixed October 30, 2026, as the record date for the sub-division of its equity shares (face value Rs. 10 to Rs. 5).
Meenakshi (India) Management Change
Meenakshi India Limited has appointed Mr. Kedarisetty Naga Mahesh Kumar as a Non-Executive Independent Director for a five-year term. He brings over 50 years of experience in finance and taxation.
- Execution
- 60 months
Meenakshi (India) Stock Split
Meenakshi India Ltd shareholders approved a stock split from face value Rs. 10 to Rs. 5. The decision was taken at the Annual General Meeting held on September 28, 2026.
Meenakshi (India) Annual General Meeting
Meenakshi India Limited conducted its 44th Annual General Meeting on September 28, 2026. Shareholders considered five agenda items, including a stock split from Rs. 10 to Rs. 5.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.